CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 8-K/A Event Material agreement · Results of operations · Unregistered share sale · Shareholder rights changed
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Results of operations · Unregistered share sale · Shareholder rights changed
- 8-K Event Regulation FD disclosure
- 4/A Grant or award Director acquired 13,252 shares (grant or award)
- 4/A Grant or award Director acquired 7,045 shares (grant or award)
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Secretary & General Counsel sold 980 shares at $3.37 ($3,303)
- 4 Open-market buy President & CEO bought 5,000 shares at $3.36 ($16,800)
- 8-K Event Regulation FD disclosure
- 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
- 4 Grant or award Secretary & General Counsel acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- 8-K Event Other events
- 8-K Event Restatement
Page 13 of 78 · 1,549 filings